Literature DB >> 12796377

The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.

Hiroaki Shiina1, Mikio Igawa, Julia Breault, Leopoldo Ribeiro-Filho, Deepa Pookot, Shinji Urakami, Masaharu Terashima, Masao Deguchi, Masaki Yamanaka, Masato Shirai, Masanori Kaneuchi, Christopher J Kane, Rajvir Dahiya.   

Abstract

beta-Catenin and transcriptional factor TCF-4 (human T-cell factor-4) genes comprise the Wnt signal. The Wnt signal pathway plays an important role in malignant transformation. We hypothesize that the beta-catenin and TCF-4 gene and Wnt signal are important in the progression of renal cell carcinoma (RCC). To test this hypothesis, we investigated TCF-4 splicing isoforms, beta-catenin, and Wnt signal pathway (cyclin D1, c-myc, c-jun, and MMP7) in three RCC cell lines (A498, Caki-1, and Caki-2), 38 primary RCCs, and 29 normal kidney samples. We also analyzed the relationship between TCF-4 gene splicing isoforms, proliferation (proliferating cell nuclear antigen labeling index), and apoptosis [antiapoptotic factors (Bcl-2 and Bcl-x(L)), proapoptotic factors (Bak and Bax), and caspase-3] in RCC samples. In 38 RCC samples, four splicing isoforms of the TCF-4 gene were present in the region between exon 12 and exon 17. Thirty (79%) of 38 RCCs and all (100%) of the normal kidney samples showed mixed isoforms with both long and short reading frames in the COOH-terminal region, whereas the remaining 8 RCC samples showed only the long-form reading frame. Two COOH-terminal-binding protein sites were present only in the long-form reading frame. The eight RCCs that demonstrated only the long reading frame isoform showed early disease progression and poor prognosis. In these 8 RCC samples, down-regulation of cyclin D1, c-myc, c-jun, and MMP7 expression was observed at the mRNA level. In addition, a marked reduction of caspase-3 expression was also found at both the mRNA and the protein level. However, the beta-catenin gene was not overexpressed at the mRNA level and protein level, and mutation and deletion were not observed in exon 3. In these three renal cell lines, there was no significant difference in TCF-4 mRNA expression before and after 5-Aza-2'-deoxycytidine treatment, and there appeared to be no splicing isoforms in the region between exon 1 and exon 11. These findings suggest that alteration in beta-catenin is an infrequent event in RCC. In samples in which beta-catenin was not overexpressed, the target genes of Wnt signal were regulated through TCF-4 splicing isoforms. The imbalance between TCF-4 gene splicing isoforms with long and short reading frames is associated with RCC progression through the inhibition of the apoptotic pathway. We demonstrate for the first time that TCF-4 gene splicing isoforms and the Wnt signal pathway can induce progression of RCC by the inhibition of apoptosis and not by the induction of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796377

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  33 in total

Review 1.  Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.

Authors:  Ola Hansson; Yuedan Zhou; Erik Renström; Peter Osmark
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

2.  Wnt signaling in kidney development and disease.

Authors:  Kaisa Pulkkinen; Subramanian Murugan; Seppo Vainio
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

3.  Wnt antagonist gene polymorphisms and renal cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koichi Nakajima; Nobuyuki Kikuno; Soichiro Yamamura; Kazumori Kawakami; Yutaka Suehiro; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

4.  Integrin-linked kinase (ILK) expression correlates with tumor severity in clear cell renal carcinoma.

Authors:  Míriam de Fátima Brasil Engelman; Rogério Mendes Grande; Marcelo Andery Naves; Marcello Fabiano de Franco; Vicente de Paulo Castro Teixeira
Journal:  Pathol Oncol Res       Date:  2012-07-20       Impact factor: 3.201

5.  TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.

Authors:  Yufu Zhu; Yang Xu; Tianze Chen; Yujian Zhang; Qiang Ma; Sunil Rauniyar; Lei Wang; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

6.  Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.

Authors:  Gangadhara Reddy Sareddy; Sundaram Challa; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

7.  Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells.

Authors:  Prabir K Chakraborty; Wing-Kee Lee; Malte Molitor; Natascha A Wolff; Frank Thévenod
Journal:  Mol Cancer       Date:  2010-05-08       Impact factor: 27.401

8.  Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.

Authors:  Zhuanyi Yang; Ying Wang; Jiasheng Fang; Fenghua Chen; Jinfang Liu; Jun Wu; Yanjin Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-03-24

9.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.

Authors:  Andreas Weise; Katja Bruser; Susanne Elfert; Britta Wallmen; Yvonne Wittel; Simon Wöhrle; Andreas Hecht
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

10.  Tissue-specific alternative splicing of TCF7L2.

Authors:  Ludmila Prokunina-Olsson; Cullan Welch; Ola Hansson; Neeta Adhikari; Laura J Scott; Nicolle Usher; Maurine Tong; Andrew Sprau; Amy Swift; Lori L Bonnycastle; Michael R Erdos; Zhi He; Richa Saxena; Brennan Harmon; Olga Kotova; Eric P Hoffman; David Altshuler; Leif Groop; Michael Boehnke; Francis S Collins; Jennifer L Hall
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.